Hexo (HYYDF) Stock Price, News & Analysis

Company Overview

Hexo Corp. is a Canadian-based cannabis company focused on the production, distribution and wholesale of cannabis products. The company cultivates premium indoor and greenhouse-grown cannabis at its flagship facility in Gatineau, Québec, and supplies packaged dried flower, pre-rolls, oils, capsules and vape formulations to provincial retailers across Canada. Hexo also develops a variety of edibles and infused beverages through partnerships in the non-alcoholic drinks segment.

In addition to its core consumer offerings, Hexo operates under several brand banners tailored to key market segments, including Zen and Original Stash for value-conscious users, and the high-potency T1 brand for experienced consumers. The company has invested in research and product development to expand into wellness-oriented categories, exploring new formulations such as transdermal patches and sublingual strips. Hexo maintains licensed processing facilities in Ontario and British Columbia, ensuring national distribution capabilities.

Founded in 2013 as Hydropothecary, Hexo went public on the Toronto Stock Exchange in 2018 under the ticker “HEXO.” Since that time, the company has pursued strategic acquisitions—such as the purchase of Redecan and Newstrike—to bolster its production capacity and broaden its product portfolio. Hexo also entered a joint venture with Molson Coors Beverage Company to develop non-alcoholic, cannabis-infused beverages, positioning itself at the convergence of two growing consumer markets.

Led by Chief Executive Officer Sebastien St-Louis and supported by a management team with deep expertise in consumer packaged goods, regulated production and research, Hexo serves customers in every Canadian province and territories through established provincial retail channels. The company continues to pursue growth opportunities in research partnerships and export markets where medical cannabis is permitted, aligning its operations with evolving regulatory frameworks and consumer preferences.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 1.40 million shs
• Average Volume: 773,571 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HYYDF Stock Analysis - Frequently Asked Questions

How do I buy shares of Hexo?

Shares of HYYDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:HYYDF
• CIK: N/A
• Web: thehydropothecary.com
• Phone: (844) 406-1852
• Fax: N/A
• Employees: 690
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A